These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Clinical characteristics of 95 patients with ocular adnexal and uveal lymphoma: treatment outcomes in extranodal marginal zone subtype. Portell CA; Aronow ME; Rybicki LA; Macklis R; Singh AD; Sweetenham JW Clin Lymphoma Myeloma Leuk; 2014 Jun; 14(3):203-10. PubMed ID: 24417911 [TBL] [Abstract][Full Text] [Related]
10. Characteristics of primary extranodal marginal zone B-cell lymphoma in Korea: conjunctiva versus other ocular adnexa. Nam SW; Woo KI; Kim YD Br J Ophthalmol; 2018 Apr; 102(4):502-508. PubMed ID: 28814410 [TBL] [Abstract][Full Text] [Related]
11. Outcome and prognostic factors in ocular adnexal lymphoma. Nola M; Lukenda A; Bollmann M; Kalauz M; Petrovecki M; Bollmann R Croat Med J; 2004 Jun; 45(3):328-32. PubMed ID: 15185428 [TBL] [Abstract][Full Text] [Related]
12. Clinicopathological Features of Ocular Adnexal Mantle-Cell Lymphoma in an International Multicenter Cohort. Knudsen MKH; Rasmussen PK; Coupland SE; Esmaeli B; Finger PT; Graue GF; Grossniklaus HE; Khong JJ; McKelvie PA; Mulay K; Ralfkiaer E; Sjö LD; Vemuganti GK; Thuro BA; Curtin J; Heegaard S JAMA Ophthalmol; 2017 Dec; 135(12):1367-1374. PubMed ID: 29121219 [TBL] [Abstract][Full Text] [Related]
13. Ocular adnexal lymphoma: a clinicopathologic study of a large cohort of patients with no evidence for an association with Chlamydia psittaci. Rosado MF; Byrne GE; Ding F; Fields KA; Ruiz P; Dubovy SR; Walker GR; Markoe A; Lossos IS Blood; 2006 Jan; 107(2):467-72. PubMed ID: 16166588 [TBL] [Abstract][Full Text] [Related]
15. Long term outcome of ocular adnexal lymphoma subtyped according to the REAL classification. Revised European and American Lymphoma. Auw-Haedrich C; Coupland SE; Kapp A; Schmitt-Gräff A; Buchen R; Witschel H Br J Ophthalmol; 2001 Jan; 85(1):63-9. PubMed ID: 11133714 [TBL] [Abstract][Full Text] [Related]
16. [Lymphoproliferative lesions of the ocular adnexa. Differential diagnostic guidelines]. Coupland SE Ophthalmologe; 2004 Feb; 101(2):197-215; quiz 216-7. PubMed ID: 15046030 [TBL] [Abstract][Full Text] [Related]
17. Ocular adnexal lymphoma staging and treatment: American Joint Committee on Cancer versus Ann Arbor. Graue GF; Finger PT; Maher E; Della Rocca D; Della Rocca R; Lelli GJ; Milman T Eur J Ophthalmol; 2013; 23(3):344-55. PubMed ID: 23397158 [TBL] [Abstract][Full Text] [Related]
18. [The clinical features and outcomes in 21 patients with ocular adnexal mucosa-associated lymphoid tissue lymphoma]. Ning F; Ye J; Wei LQ; Li X; Wang JW Zhonghua Nei Ke Za Zhi; 2012 Oct; 51(10):784-7. PubMed ID: 23290977 [TBL] [Abstract][Full Text] [Related]
19. Feasibility of the TNM-based staging system of ocular adnexal extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma). Lee SE; Paik JS; Cho WK; Choi BO; Lee SN; Jung SE; Park KS; Kang CS; Kim SH; Yang SW; Cho SG Am J Hematol; 2011 Mar; 86(3):262-6. PubMed ID: 21328439 [TBL] [Abstract][Full Text] [Related]
20. Extranodal marginal zone lymphoma in the ocular region: clinical, immunophenotypical, and cytogenetical characteristics. Sjö LD; Heegaard S; Prause JU; Petersen BL; Pedersen S; Ralfkiaer E Invest Ophthalmol Vis Sci; 2009 Feb; 50(2):516-22. PubMed ID: 18775860 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]